Protagonist Therapeutics Inc
(PTGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,277 | -14,103 | -38,924 | -25,059 | -16,324 |
| Depreciation Amortization | 1,000 | 495 | 733 | 703 | 358 |
| Income taxes - deferred | -1,446 | 180 | -658 | N/A | N/A |
| Accounts receivable | -302 | -474 | -2,771 | -2,770 | -3,968 |
| Accounts payable and accrued liabilities | -3,249 | 846 | 5,491 | 4,381 | 1,290 |
| Other Working Capital | 26,739 | -5,213 | -18,017 | -20,303 | -17,400 |
| Other Operating Activity | 7,543 | 1,607 | 4,199 | 3,236 | 5,508 |
| Operating Cash Flow | $-12,992 | $-16,662 | $-49,947 | $-39,812 | $-30,536 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,058 | -166 | -486 | -424 | -276 |
| Purchase Of Investment | -52,459 | -21,726 | -71,060 | -51,947 | -39,012 |
| Sale Of Investment | 44,400 | 26,000 | 73,759 | 50,035 | 27,035 |
| Investing Cash Flow | $-9,117 | $4,108 | $2,213 | $-2,336 | $-12,253 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,020 | 390 | 24,115 | 23,636 | 604 |
| Financing Cash Flow | $11,020 | $390 | $24,115 | $23,636 | $604 |
| Exchange Rate Effect | -1 | 8 | -177 | -90 | 20 |
| Beginning Cash Position | 82,693 | 82,693 | 106,489 | 106,489 | 106,489 |
| End Cash Position | 71,603 | 70,537 | 82,693 | 87,887 | 64,324 |
| Net Cash Flow | $-11,090 | $-12,156 | $-23,796 | $-18,602 | $-42,165 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,992 | -16,662 | -49,947 | -39,812 | -30,536 |
| Capital Expenditure | -1,058 | -166 | -486 | -424 | -276 |
| Free Cash Flow | -14,050 | -16,828 | -50,433 | -40,236 | -30,812 |